IJzermans JNM - Search Results

1

Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis.

Mammadov RA, Selten JW, Roest HP, Verhoeven CJ, Maroni L, Bril SI, Tolenaars D, Gadjradj PS, van de Graaf SFJ, Oude Elferink RPJ, Kwekkeboom J, Metselaar HJ, Peppelenbosch MP, Beuers U, IJzermans JNM, van der Laan LJW. Mammadov RA, et al. Among authors: ijzermans jnm. Transplantation. 2023 Aug 1;107(8):1764-1775. doi: 10.1097/TP.0000000000004563. Epub 2023 Mar 29. Transplantation. 2023. PMID: 36978227

2

[Criteria for and results of liver transplantation in patients with acute liver insufficiency].

Metselaar HJ, Tilanus HW, Ijzermans JN, Groenland TN, van den Berg B, Schalm SW. Metselaar HJ, et al. Ned Tijdschr Geneeskd. 1994 Sep 17;138(38):1901-4. Ned Tijdschr Geneeskd. 1994. PMID: 7935935 Dutch.

3

"Ecstasy" and liver transplantation.

Ijzermans JN, Tilanus HW, De Man RA, Metselaar HJ. Ijzermans JN, et al. Ann Med Interne (Paris). 1993;144(8):568. Ann Med Interne (Paris). 1993. PMID: 8179247 No abstract available.

4

Mycophenolate mofetil and prednisone as maintenance treatment after kidney transplantation.

van Gelder T, Klaassen RJ, van Riemsdijk-van Overbeeke I, IJzermans JN, Weimar W. van Gelder T, et al. Transplantation. 1997 May 27;63(10):1530-1. doi: 10.1097/00007890-199705270-00029. Transplantation. 1997. PMID: 9175824

5

Tumor recurrence in liver grafts: two animal models.

Schotman SN, van Ijken MG, Marquet RL, Zondervan PE, IJzermans JN. Schotman SN, et al. Transplant Proc. 1998 Jun;30(4):1052-3. doi: 10.1016/s0041-1345(98)00148-1. Transplant Proc. 1998. PMID: 9636426 No abstract available.

6

The vanishing importance of age in renal transplantation.

Roodnat JI, Zietse R, Mulder PG, Rischen-Vos J, van Gelder T, IJzermans JN, Weimar W. Roodnat JI, et al. Transplantation. 1999 Feb 27;67(4):576-80. doi: 10.1097/00007890-199902270-00015. Transplantation. 1999. PMID: 10071030

7

Cholesterol as an independent predictor of outcome after renal transplantation.

Roodnat JI, Mulder PG, Zietse R, Rischen-Vos J, van Riemsdijk IC, IJzermans JN, Weimar W. Roodnat JI, et al. Transplantation. 2000 Apr 27;69(8):1704-10. doi: 10.1097/00007890-200004270-00029. Transplantation. 2000. PMID: 10836384

8

Importance of portal flow diversion in experimental auxiliary partial orthotopic liver transplantation.

de Jonge J, Zondervan PE, IJzermans JN, Metselaar HJ, Tilanus HW. de Jonge J, et al. Transplantation. 2000 Jul 15;70(1):44-7. Transplantation. 2000. PMID: 10919573

9

A comparison of the costs and effects of liver transplantation for acute and for chronic liver failure.

van Agthoven M, Metselaar HJ, Tilanus HW, de Man RA, IJzermans JN, Martin van Ineveld BM. van Agthoven M, et al. Transpl Int. 2001;14(2):87-94. doi: 10.1007/s001470050852. Transpl Int. 2001. PMID: 11370172

10

In vitro cytokine production of TNFalpha and IL-13 correlates with acute liver transplant rejection.

Warlé MC, Farhan A, Metselaar HJ, Hop WC, van der Plas AJ, Kap M, de Rave S, Kwekkeboom J, Zondervan PE, IJzermans JN, Tilanus HW, Pravica V, Hutchinson IV, Bouma GJ. Warlé MC, et al. Hum Immunol. 2001 Nov;62(11):1258-65. doi: 10.1016/s0198-8859(01)00321-4. Hum Immunol. 2001. PMID: 11704289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

642 results

Search Page